Title: CLL Lymphoma Focus Meeting 2023
Activity Date: July 14-15 2023
This activity is jointly provided by Medical Education Resources and MD Education
Target Audience
This activity has been designed to meet the educational needs of health care professionals involved in the care of patients with Chronic Lymphocytic Leukemia and Lymphoma.
Program Overview
The meeting will provide participants with a unique oppurtunity for sharing knowledge, skills and experiences. In addition, thhis event will provide a platform for networking with many of the worlds leading experts, focusing on reviewing and assessing best practices and state-of-the-art treatments to address the generic changes aimed at identifying and preventing hematologic maliginancies. The meeting program will include presentations, round-table dicussions, debates with audience participation, oral abtracts and a number of informal social gatherings.
Educational Objectives
CLL
- Evaluate the progress in the development of new therapies and best practices for the treatment of CLL.
- Gain further insight into the treatment of patients with small molecules.
- Understand the pathogenesis of CLL and the importance of MRD.
- Appraise specific treatment approaches for Richter’s syndrome and of patients with P53 aberrations.
- Employ approaches to translate new findings into clinical practice.
- Have increased awareness of potential treatments under investigation and in subsequent clinical trials.
Lymphoma
- Gain insight into the molecular classification of lymphomas.
- Evaluate the progress in the development of new therapies and best practices for the treatment of lymphoma, with a review clinical research and trials.
- Understand the treatment and management strategies for lymphomas.
- Understand the role of CAR-T Cells therapy and toxicity management.
- Employ approaches to translate new findings into clinical practice.
Physician Credit
Medical Education Resources designates this live activity for a maximum of 13 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Relevant Financial Relationships
Medical Education Resources ensure balance, independence, objectivity and scientific rigor in all our educational acitivites. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards off experimental design, data collection, and analysis. MER is commited to providing learners with high-quality CE activites that promote improvements or quality in health care and not the business of interest of an ineligible company.
Fee Information
There are no fees for Healthcare Providers for this activity.
